ECKERT R ANDREW 4

What Happened

• Andrew R. Eckert, a director of Maravai LifeSciences Holdings, Inc. (MRVI), was granted 46,293 restricted stock units (RSUs) on May 26, 2026. The grant is reported as an award (transaction code A) at a grant price of $0.00 (no cash paid at grant).

Key Details

• Transaction date: 2026-05-26; Form 4 filed: 2026-05-28 (filed within the typical two-business-day window).
• Grant amount and price: 46,293 RSUs @ $0.00 (total reported value at grant = $0).
• Shares owned after the transaction: not disclosed in the supplied report.
• Footnote: RSUs vest in full upon the earlier of one year from the grant date or the date of the 2027 Maravai annual meeting of stockholders.
• No tax-withholding or disposition codes were reported with this entry.

Context

• RSU grants are awards that convert into common shares upon vesting; they are not open-market purchases or sales and do not reflect an immediate cash investment or sale by the insider. Such grants are common compensation for directors and employees and should be viewed as a compensation/retention event rather than a direct buy or sell signal.